EdgeRock Capital »

Neurocrine Biosciences shares owned by EdgeRock Capital

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by EdgeRock Capital from 13F filings

Historical chart of EdgeRock Capital investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by EdgeRock Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by EdgeRock Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 217 141.74

More positions owned by EdgeRock Capital

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Msci Usa Min Vol (USMV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Msci Usa Mmentm (MTUM)
Apple (AAPL)
First Tr Exch Traded Fd Iii Managd Mun Etf (FMB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii Short Term Treas (TBLL)
Amazon (AMZN)
First Tr Exchange-traded First Tr Enh New (FTSM)

View all positions for EdgeRock Capital

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences